Comparing Lynparza vs Paclitaxel
| Lynparza Remove Lynparza from your drug comparison | Paclitaxel Remove Paclitaxel from your drug comparison |
|---|
| Lynparza olaparib Remove Lynparza from your drug comparison | Paclitaxel Remove Paclitaxel from your drug comparison | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Ovarian Cancer, Prostate Cancer, Breast Cancer - Metastatic, Pancreatic Cancer. Lynparza may also be used for purposes not listed in this medication guide. |
Prescribed for Breast Cancer - Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Kaposi's Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Wilms' Tumor. paclitaxel may also be used for... View more |
||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
Ratings & Reviews |
|||||||||||||||||
Drug Class |
|||||||||||||||||
Side Effects |
|||||||||||||||||
|
Common side effects include: upper respiratory tract infection, anemia, decreased hemoglobin, increased mcv, increased serum creatinine, nasopharyngitis, nausea, pharyngitis, vomiting, cough, and dyspnea. See the full Lynparza side effects document. |
Commonly reported side effects include: hypotension, nausea and vomiting, arthralgia, myalgia, alopecia, diarrhea, hypersensitivity condition, mucositis, skin rash, ecg abnormality, increased serum alkaline phosphatase, increased serum aspartate aminotransferase, infusion site reaction, peripheral neuropathy, and flushing. See the full paclitaxel side effects document. |
||||||||||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||||||||||
View all Lynparza prices |
View all paclitaxel prices |
||||||||||||||||
Generic Availability |
|||||||||||||||||
|
No |
Yes (this medicine) |
||||||||||||||||
Dosage Form(s) Available |
|||||||||||||||||
|
|
||||||||||||||||
Brand Names |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||||||||||
|
11.9 hours |
17.4 hours |
||||||||||||||||
CSA Schedule**View glossary of terms. |
|||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category |
|||||||||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||||||||||
FDA Alerts |
|||||||||||||||||
|
N/A |
|||||||||||||||||
Drug Interactions |
|||||||||||||||||
|
A total of 471 drugs are known to interact with Lynparza:
|
A total of 359 drugs are known to interact with paclitaxel:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||||||||||
|
|
||||||||||||||||
Disease Interactions |
|||||||||||||||||
First Approval Date |
|||||||||||||||||
|
December 19, 2014 |
N/A |
||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
More Information |
|||||||||||||||||
Consumer Resources |
|||||||||||||||||
Professional Resources |
|||||||||||||||||
Related Treatment Guide |
|||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.